Adrenal Insufficiency

Endocrinology: Adult and Pediatric

Volumn 2-2, Issue , 2015, Pages 1763-1774.e4

  Barthel, Andreas ^a,b   Willenberg, Holger S ^c   Gruber, Matthias ^d   Bornstein, Stefan R ^b,e  

^a Endokrinologikum Ruhr   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85013998066     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-18907-1.00102-5     Document Type: Chapter

References (151)

1. Charmandari E., Nicolaides N.C., Chrousos G.P. Adrenal insufficiency. Lancet 2014, 383:2152-2167.
2. Bornstein S.R. Predisposing factors for adrenal insufficiency. N Engl J Med 2009, 360(22):2328-2339.
3. Lovas K., Husebye E.S. High prevalence and increasing incidence of Addison's disease in western Norway. Clin Endocrinol 2002, 56:787-791.
4. Kong M.F., Jeffcoate W. Eighty-six cases of Addison's disease. Clin Endocrinol 1994, 41:757-761.
5. Husebye E., Løvås K. Pathogenesis of primary adrenal insufficiency. Best Pract Res Clin Endocrinol Metab 2009, 23(2):147-157.
6. Eustachi B, Fallopio G: Opuscula anatomica. Venice: M.A. Ulmus; 1563.
7. Addison T. On the constitutional and local effects of disease of the suprarenal capsules 1855, Highly, London.
8. Brown-Sequard C.E. Recherches experimentales sur la physiologie et la pathologie des capsules surrenales. Acad Sci Paris 1856, 43:422-425.
9. Trousseau A. Bronze Addison's disease. Arch Gen Med 1856, 8:478.
10. Osler W. Case of Addison's disease: Death during treatment with the supravital extra. Bull Johns Hopkins Hosp 1896, 7:208-209.
11. Wintersteiner O.P., Pfiffner J. Chemical studies on the adrenal cortex: II. J Biol Chem 1935, 111:599-612.
12. Kendall E.C. A chemical and physiological investigation of the suprarenal cortex. Symp Quant Biol 1937, 5:299.
13. de Fremery P., Laquer E., Reichstein T., et al. Corticosterone: A crystalloid compound with biological activity of the adrenal-cortical hormone. Nature 1937, 139:26-27.
14. Grollman A. Physiological and chemical studies on the adrenal cortical hormone. Symp Quant Biol 1937, 5:313.
15. Sarett L. The synthesis of hydrocortisone from desoxycholic acid. J Biol Chem 1946, 162:601.
16. Hench P.S., Slocumb C.H., Barnes A.R., et al. The effects of the adrenal cortical hormone, compound E, on the acute phase of rheumatic fever: A preliminary report. Proc Mayo Clin 1949, 24:277-297.
17. Thorn G.W., Forsham P.H. The treatment of adrenal insufficiency. Rec Prog Horm Res 1949, 4:229.
18. Cushing H.W. The pituitary body and its disorders 1912, JB Lippincott, Philadelphia.
19. Harris G.W. Neural control of the pituitary gland. Physiol Rev 1948, 28:139.
20. Li C.H., Dixon J.S., Chung D. The structure of bovine corticotropin. J Am Chem Soc 1958, 80:2587-2596.
21. Vale W., Spiers J., Rivier C., et al. Characterization of a 41 residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213:585-587.
22. Sampson P.A., Brooke B.N., Winstone N.E. Biochemical confirmation of collapse due to adrenal failure. Lancet 1961, 1:1377.
23. Speigel R.J., Vigersky R.A., Oliff A.I. Adrenal suppression after short term corticosteroid therapy. Lancet 1979, 1:630-632.
24. Olefsky J.M. The effect of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest 1975, 56:1499-1508.
25. Reidenberg M.M., Ohler E.A., Seuy R.W., et al. Hemodynamic changes in adrenalectomized dogs. Endocrinology 1963, 72:918-923.
26. Clarke A.P.W., Cleghorn R.A., Ferguson J.K.W., et al. Factors concerned in the circulatory failure of adrenal insufficiency. J Clin Invest 1947, 26:359-363.
27. Lefer A.M., Verrier R.L., Carson W.W. Cardiac performance in experimental adrenal insufficiency. Circ Res 1968, 22:817-827.
28. Rodan S.B., Rodan G.A. Dexamethasone effects on beta-adrenergic receptors and adenylate cyclase regulatory proteins Gs and Gi in ROS 17/2.8 cells. Endocrinology 1986, 118:2510-2518.
29. Livingstone J.N., Lockwood D.H. Effect of glucocorticoids on the glucose transport system of isolated fat cells. J Biol Chem 1975, 250:8353-8360.
30. Marver D., Kokko J.P. Renal target sites and the mechanism of action of aldosterone. Miner Electrolyte Metab 1983, 9:1-32.
31. Neufeld M., MacLaren N., Blizzard R. Autoimmune polyglandular syndromes. Pediatr Ann 1980, 9:154-162.
32. Betterle C., Greggio N.A., Valpato M. Clinical review 93: Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 1998, 83:1049-1055.
33. Betterle C., Valpato M., Greggio N.A., et al. Type 2 polyglandular autoimmune disease (Schmidt's syndrome). J Pediatr Endocrinol Metab 1996, 9:113-123.
34. Dittmar M., Kahaly G.J. Extensive personal experience. Polyglandular autoimmune syndromes: Immunogenetics and long-term follow up. J Clin Endocrinol Metab 2003, 88:2983-2992.
35. Eisenbarth G.S., Wilson P.N., Ward F., et al. The polyglandular failure syndrome: Disease inheritance, HLA-type, and immune function studies in patients and families. Ann Intern Med 1979, 91:528-533.
36. Betterle C., Scarpa R., Garelli S., Morlin L., Lazzarotto F., Presotto F., Coco G., Masiero S., Parolo A., Albergoni M.P., Favero R., Barollo S., Salvà M., Basso D., Chen S., Rees Smith B., Furmaniak J., Mantero F. Addison's disease: A survey on 633 patients in Padova. Eur J Endocrinol 2013, 169(6):773-784.
37. Husebye E.S., Allolio B., Arlt W., Badenhoop K., Bensing S., Betterle C., Falorni A., Gan E.H., Hulting A.L., Kasperlik-Zaluska A., Kämpe O., Løvås K., Meyer G., Pearce S.H. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 2014, 275(2):104-115.
38. Cutolo M. Autoimmune polyendocrine syndromes. Autoimmun Rev 2014, 13(2):85-89.
39. Devendra D., Eisenbarth G.S. Immunologic endocrine disorders. J Allergy Clin Immunol 2003, 111:S624-S636.
40. Coco G., Dal Pra C., Presotto F., et al. Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies. J Clin Endocrinol Metab 2006, 91:1637-1645.
41. Betterle C., Dal Pra C., Mantero F., et al. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: Autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002, 23:327-364.
42. Neufeld M., Maclaren N.K., Blizzard R.M. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune syndromes. Medicine 1981, 60:355-362.
43. Ahonen P., Myllärniemi S., Sipilä I., et al. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990, 322:1829-1836.
44. Finnish-German APCED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 1997, 17:399-403.
45. Nagamine K., Peterson P., Scott H.S., et al. Positional cloning of the APECED gene. Nat Genet 1997, 17:393-398.
46. Perheentupa J. APS1/APECED: The clinical disease and therapy. Endocrinol Metab Clinic North Am 2002, 31:295-320.
47. Pearce S.H., Cheetham T.D. Autoimmune polyendocrinopathy syndrome type 1: Treat with kid gloves. Clin Endocrinol (Oxf) 2001, 54:433-435.
48. Barker J.M., Eisenbarth G.S. Autoimmune polyendocrine syndromes. Type 1 diabetes: Molecular, cellular, and clinical immunology 2003, Barbara Davis Center for Childhood Diabetes (Web only), Denver. G.S. Eisenbarth (Ed.).
49. Söderbergh A., Myhre A.G., Ekwall O., et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2004, 89:557-562.
50. Alimohammadi M., Björklund P., Hallgren A., et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med 2008, 358:1018-1028.
51. Falorni A., Laurenti S., Santeusanio F. Autoantibodies in autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am 2002, 31:369-389.
52. Laureti S., Vecchi L., Santeusanio F., et al. Is the prevalence of Addison's disease underestimated?. J Clin Endocrinol Metab 1999, 84:1762.
53. Eisenbarth G.S., Wilson P.N., Ward F., et al. The polyglandular failure syndrome: Disease inheritance, HLA-type, and immune function studies in patients and families. Ann Intern Med 1979, 91:528-533.
54. Peterson P., Uibo R., Krohn K.J. Adrenal autoimmunity: Results and developments. Trends Endocrinol Metab 2000, 11:285-290.
55. Partanen J., Peterson P., Westman P., et al. Major histocompatibility complex class II and III in Addison's disease: MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility. Hum Immunol 1994, 41:135-140.
56. Ten S., New M., MacLaren N. Clinical review 130: Addison's disease. J Clin Endocrinol Metab 2001, 86:2909-2922.
57. Wildin R.S., Freitas A. IPEX and FOXP3: Clinical and research perspectives. J Autoimmun 2005, 25:56-62.
58. Sarosi G.A., Voth D.W., Dahl B.A., et al. Disseminated histoplasmosis: Results of long-term follow-up. Ann Intern Med 1971, 75:511-516.
59. Levine E. CT evaluation of active adrenal histoplasmosis. Urol Radiol 1991, 13:103-106.
60. Osa S.R., Peterson R.E., Roberts R.B. Recovery of adrenal reserve following treatment of South American blastomycosis. Am J Med 1981, 71:298-301.
61. Abernathy R.S., Melby J.C. Addison's disease in North American blastomycosis. N Engl J Med 1962, 266:552-554.
62. Glasgow B.J., Steinsapir B.S., Anders K., et al. Adrenal pathology in the acquired immunodeficiency syndrome. Am J Clin Pathol 1985, 84:594-597.
63. Guerra I., Kimmel P.L. Hypokalemic adrenal crisis in a patient with AIDS. South Med J 1991, 84:1265-1267.
64. Arik N., Tasdemir I., Karaaslan Y., et al. Subclinical adrenocortical insufficiency in renal amyloidosis. Nephron 1990, 56:246-248.
65. Hasan R.I., Yonan N.A., Lawson R.A. Adrenal insufficiency due to bilateral metastases from oat cell carcinoma of the esophagus. Eur J Cardiothorac Surg 1991, 5:336-337.
66. Mandanas S., Boudina M., Chrisoulidou A., Xinou K., Margaritidou E., Gerou S., Pazaitou-Panayiotou K. Acute adrenal insufficiency following arthroplasty: A case report and review of the literature. BMC Res Notes 2013, 6:370.
67. Satta M.A., Corsello S.M., Della Casa S., et al. Adrenal insufficiency as the first clinical manifestation of the primary antiphospholipid antibody syndrome. Clin Endocrinol (Oxf) 2000, 52:123-126.
68. Feurstein B., Streeten D.H.F. Recovery of adrenal function after failure resulting from traumatic bilateral adrenal hemorrhages. Ann Intern Med 1991, 115:785-786.
69. New M.I. Diagnosis and management of congential adrenal hyperplasia. Annu Rev Med 1998, 49:311-328.
70. Lin D., Sugawara T., Strauss J.F., et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995, 267:1828-1831.
71. Schaumberg H., Powers J.M., Raine C.S., et al. Adrenoleukodystrophy: A clinical and pathological study of 17 cases. Arch Neurol 1975, 32:577-585.
72. Johnson A.B., Ascauhberg H.H., Powers T.M. Histochemical characteristics of the striated inclusions of adrenoleukodystrophy. J Histochem Cytochem 1976, 24:725-730.
73. Griffen J.W., Goren E., Schaumberg H. Adrenomyelopathy: A probable variant of adrenoleukodystrophy. Neurology 1977, 27:1107-1111.
74. Schaumberg H., Powers J.M., Raine C.S. Adrenomyeloneuropathy: General, pathologic, neuropathologic, and biochemical aspects. Neurology 1977, 27:1114-1120.
75. Laureti S., Casucci G., Santeusanio F., et al. X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison disease in young adult male patients. J Clin Endocrinol Metab 1996, 81:470-474.
76. Mosser J., Douar A.M., Sarde C.O., et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993, 361:726-730.
77. Aubourg P., Blanche S., Jambaquë I., et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 1990, 322:1860-1866.
78. Morris D.G., Kola B., Borboli N., et al. Identification of ACTH receptor mRNA in the human pituitary and its loss of expression in pituitary adenomas. J Clin Endocrinol Metab 2003, 88:6080-6087.
79. Clark A.J., McLoughlin L., Grossman A. Familial glucocorticoid Deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet 1993, 341:461-462.
80. Clark A.J., Weber A. Adrenocorticotropin insensitivity syndromes. Endocr Rev 1998, 19:828-843.
81. Metherell L.A., Chapple J.P., Cooray S., et al. Mutations in MRAP, encoding a novel interacting partner of the ACTH receptor, cause Familial Glucocorticoid Deficiency Type 2. Nat Genet 2005, 37:166-170.
82. Clark A.J.L., Metherell L.A., Cheetham M.E., et al. Inherited ACTH insensitivity illuminates the mechanisms of ACTH action. Trends Endocrinol Metab 2005, 16:451-457.
83. Meimaridou E., Hughes C.R., Kowalczyk J., Chan L.F., Clark A.J., Metherell L.A. ACTH resistance: Genes and mechanisms. Endocr Dev 2013, 24:57-66.
84. Meimaridou E., Hughes C.R., Kowalczyk J., Guasti L., Chapple J.P., King P.J., Chan L.F., Clark A.J., Metherell L.A. Familial glucocorticoid deficiency: New genes and mechanisms. Mol Cell Endocrinol 2013, 371(1-2):195-200.
85. Tullio-Pelet A., Salomon R., Hadj-Rabia S., et al. Mutant WD-repeat protein in triple-A syndrome. Nat Genet 2000, 26:332-335.
86. Handschug K., Sperling S., Yoon S.-J.K., et al. Triple A syndrome is caused by mutations in AAAs, a new WD-repeat protein gene. Hum Mol Genet 2001, 10:283-290.
87. Houlden H., Smith S., de Carvalho M., et al. Clinical and genetic characterisation of families with triple A (Allgrove) syndrome. Brain 2002, 25:2681-2690.
88. Phelan J.K., McCabe E.R. Mutations in NR0B1 (DAX1) and NR5A1 (SF1) responsible for adrenal hypoplasia congenital. Hum Mutat 2001, 18:472-487.
89. Reutens A.T., Achermann J.C., Ito M., et al. Clinical and functional effects of mutations in DAX-1 gene in patients with adrenal hypoplasia congenital. J Clin Endocrinol Metab 1999, 84:504-511.
90. Lin L., Achermann J.C. Inherited adrenal hypoplasia: Not just for kids!. Clin Endocrinol (Oxf) 2004, 60:529-537.
91. Graber A.L., Ney R.L., Nicholson W.E., et al. Natural history of pituitary-adrenal recovery following long-term suppression with corticosteroids. J Clin Endocrinol Metab 1965, 25:11-17.
92. Staughten R.C.D., August P.J. Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate. Br Med J 1975, 2:419-421.
93. Hug V., Kau S., Hertobagi G.N., et al. Adrenal failure in patients with breast carcinoma after long-term treatment of cyclic alternating oestrogen progesterone. Br J Cancer 1991, 63:454-456.
94. Comtois R., Beauregard H., Somma M., et al. The clinical and endocrine outcome to transsphenoidal microsurgery of non-secreting pituitary adenomas. Cancer 1991, 68:860-866.
95. Verhage T.L., Godfried M.H., Alberts C. Hypothalamic-pituitary dysfunction with adrenal insufficiency and hyperprolactinemia in sarcoidosis. Sarcoidosis 1990, 7:139-141.
96. Erdkamp F.L., Gams R.O., Hoorntje S.J. Endocrine organ failure due to systemic AA-amyloidosis. Neth J Med 1991, 38:24-28.
97. Asa S.L., Bilbao J.M., Kovacs K., et al. Lymphocytic hypophysitis of pregnancy resulting in hypopituitarism: A distinct clinicopathologic entity. Ann Intern Med 1981, 95:166-171.
98. Mirakian R., Cudworth A.G., Bottazzo G.F., et al. Autoimmunity to anterior pituitary cells and the pathogenesis of insulin-dependent diabetes mellitus. Lancet 1982, 1:755-759.
99. Bellastella A., Bizzarro A., Coronella C., et al. Lymphocytic hypophysitis: A rare or underestimated disease?. Eur J Endocrinol 2003, 149:363-376.
100. Pulichino A.M., Vallette-Kasic S., Couture C., et al. Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency. Genes Dev 2003, 15:711-716.
101. Oelker W. Hyponatremia in inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med 1989, 321:492-496.
102. Zelissen P.M. Addison patients in the Netherlands: Medical report of the survey 1994, Dutch Addison Society, The Hague.
103. Oelkers W. Adrenal insufficiency. N Engl J Med 1996, 335:1206-1212.
104. Stewart P.M. The adrenal cortex. Williams textbook of endocrinology 2003, 525-532. Saunders, Philadelphia. P.R. Larsen, H.M. Kronenberg, S. Melmed (Eds.).
105. Allolio B., Arlt W. DHEA treatment: Myth or reality?. Trends Endocrinol Metab 2002, 13:288-294.
106. Claussen M.S., Landercasper J., Cogbill T.H. Acute adrenal insufficiency presenting as shock after trauma and surgery: Three cases and a review of the literature. J Trauma 1992, 32:94-100.
107. Zhao Y., Jiang S., Zhao X. Hyperacute adrenal insufficiency after hemorrhagic shock: Facts and fiction. J Trauma Acute Care Surg 2013 Sep, 75(3):537-538.
108. Kanczkowski W., Alexaki V.I., Tran N., Großklaus S., Zacharowski K., Martinez A., Popovics P., Block N.L., Chavakis T., Schally A.V., Bornstein S.R. Hypothalamo-pituitary and immune-dependent adrenal regulation during systemic inflammation. Proc Natl Acad Sci U S A 2013, 110(36):14801-14806.
109. Kanczkowski W., Chatzigeorgiou A., Grossklaus S., Sprott D., Bornstein S.R., Chavakis T. Role of the endothelial-derived endogenous anti-inflammatory factor Del-1 in inflammation-mediated adrenal gland dysfunction. Endocrinology 2013, 154(3):1181-1189.
110. Sprung C.L., Annane D., Keh D., Moreno R., Singer M., Freivogel K., Weiss Y.G., Benbenishty J., Kalenka A., Forst H., Laterre P.F., Reinhart K., Cuthbertson B.H., Payen D., Briegel J. CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358(2):111-124.
111. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., Sevransky J.E., Sprung C.L., Douglas I.S., Jaeschke R., Osborn T.M., Nunnally M.E., Townsend S.R., Reinhart K., Kleinpell R.M., Angus D.C., Deutschman C.S., Machado F.R., Rubenfeld G.D., Webb S.A., Beale R.J., Vincent J.L., Moreno R. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41(2):580-637.
112. Bornstein S.R., Gonzalez-Hernandez J.A., Ehrhart-Bornstein M., Adler G., Scherbaum W.A. Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J Clin Endocrinol Metab 1994, 78(1):225-232.
113. Bornstein S.R., Breidert M., Ehrhart-Bornstein M., Kloos B., Scherbaum W.A. Plasma catecholamines in patients with Addison's disease. Clin Endocrinol (Oxf) 1995, 42(2):215-218.
114. Merke D.P., Chrousos G.P., Eisenhofer G., Weise M., Keil M.F., Rogol A.D., Van Wyk J.J., Bornstein S.R. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med 2000, 343(19):1362-1368.
115. Zuckerman-Levin N., Tiosano D., Eisenhofer G., Bornstein S., Hochberg Z. The importance of adrenocortical glucocorticoids for adrenomedullary and physiological response to stress: A study in isolated glucocorticoid deficiency. J Clin Endocrinol Metab 2001, 86(12):5920-5924.
116. Pearson O.H., Whitmore W.F., West C.D. Clinical and metabolic studies of bilateral adrenalectomy for advanced cancer in man. Surgery 1953, 34:543-552.
117. El Fassi D., Nielsen G. Hyperkalemia: A clue to the diagnosis of adrenal insufficiency. Circulation 2013, 128(24):2620-2621.
118. Lipsett M.B., Pearson O.H. Pathophysiology and treatment of adrenal crisis. N Engl J Med 1956, 254:511-515.
119. Boykin T., DeTorrente A., Erikson A. The role of plasma vasopressin in impaired water excretion of glucocorticoid deficiency. J Clin Invest 1978, 62:738-746.
120. Grossman A.B. Clinical Review: The diagnosis and management of central hypoadrenalism. J Clin Endocrinol Metab 2010, 95(11):4855-4863.
121. Kehlet H., Binder C. Value of an ACTH test in assessing hypothalamic-pituitary-adrenocortical function in glucocorticoid-treated patients. Br Med J 1973, 2:147-152.
122. Mukherjee J.J., Jacome de Castro J., Kaltsas G., et al. A comparison of insulin tolerance/glucagon tests with the short ACTH stimulation test for assessment of hypothalamo-pituitary-adrenal axis in the early post-operative period after hypophysectomy. Clin Endocrinol (Oxf) 1997, 47:51-60.
123. Calis M., Gokce C., Ates F., et al. Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. J Endocrinol Invest 2004, 27:42-46.
124. Rasmuson S., Olsson T., Hagg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 1996, 44:151-156.
125. Jones S.L., Trainer P.J., Perry L., et al. An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol 1994, 41:123-128.
126. Betterle C., Volpato M., Pedini B., et al. Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison's disease: Comparison of immunofluorescence and immunoprecipitation assays. J Clin Endocrinol Metab 1999, 84:618-622.
127. Kehlet H., Madsen S.N., Binder C. Cortisol and cortisone acetate in parenteral glucocorticoid therapy. Acta Med Scand 1974, 195:421-425.
128. Fariss B.L., Hane S., Shinsako H. Comparison of absorption of cortisone acetate and hydrocortisone hemisuccinate. J Clin Endocrinol Metab 1978, 47:1137-1140.
129. Baker S.J.K., Hunt P.J., Wass J.A.H. Assessing the potential for fine tuning the management of Addison's disease/steroid replacement therapy. 188th Society for Endocrinology (UK) meeting, London. J Endocrinol Abstract Suppl 1997, 155:P2.
130. Lovas K., Loge J.H., Husebye E.S. Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf) 2002, 56:581-588.
131. Arlt W., Callies F., van Vlijmen J.C., et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999, 341:1013-1020.
132. Hunt P.J., Gurnell E.M., Huppert F.A., et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 2000, 85:4650-4656.
133. Lovas K., Gebre-Medhin G., Trovik T.S., et al. Replacement of dehydroepiandrosterone in adrenal failure: No benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 2003, 88:1112-1118.
134. Gurnell E.M., Hunt P.J., Curran S.E., et al. Long term DHEA replacement in primary adrenal insufficiency: A randomized, controlled trial. J Clin Endcrinol Metab 2008, 93:400-409.
135. Udelsman R., Chrousos G.P., Loriaux D.L. Adaptation during surgical stress. J Clin Invest 1986, 77:1377-1381.
136. Cooper M.S., Stewart P.M. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003, 348:727-734.
137. Arafah B.M. Review: Hypothalamic pituitary adrenal function during critical illness: Limitations of current assessment methods. J Clin Endocrinol Metab 2004, 91:3725-3745.
138. Hamrahian A.H., Oseni T.S., Arafah B.M. Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004, 350:1629-1638.
139. Ho J.T., Al-Musalhi H., Chapman M.J., et al. Septic shock and sepsis: A comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab 2006, 91:105-114.
140. Loriaux L. Glucocorticoid therapy in the intensive care unit. N Engl J Med 2004, 350:1601-1602.
141. Russell J.A. Management of sepsis. N Engl J Med 2006, 355:1699-1713.
142. The Veterans Administration Systemic Sepsis Cooperative Study Group Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987, 317:659-665.
143. Bone R.C., Fisher C.J., Clemmer T.P., et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987, 317:653-658.
144. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871.
145. Sprung C.L., Annane D., Keh D., et al. for the CORTICUS Study Group: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358:111-124.
146. Grossman A., Johannsson G., Quinkler M., Zelissen P. Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: Clinical insights from across Europe. Eur J Endocrinol 2013 Oct 21, 169(6):R165-R175.
147. Quinkler M., Hahner S., Johannsson G., Stewart P.M. Saving lives of patients with adrenal insufficiency: A pan-European initiative?. Clin Endocrinol (Oxf) 2014 Mar, 80(3):319-321.
148. Johannsson G., Nilsson A.G., Bergthorsdottir R., Burman P., Dahlqvist P., Ekman B., Engström B.E., Olsson T., Ragnarsson O., Ryberg M., Wahlberg J., Biller B.M., Monson J.P., Stewart P.M., Lennernäs H., Skrtic S. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: A prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab 2012 Feb, 97(2):473-481.
149. Whitaker M.J., Debono M., Huatan H., Merke D.P., Arlt W., Ross R.J. An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure. Clin Endocrinol (Oxf) 2014, 80(4):554-561.
150. Tajima T., Okada T., Ma X.M., Ramsey W., Bornstein S., Aguilera G. Restoration of adrenal steroidogenesis by adenovirus-mediated transfer of human cytochromeP450 21-hydroxylase into the adrenal gland of21-hydroxylase-deficient mice. Gene Ther 1999 Nov, 6(11):1898-1903.
151. Ludwig B., Reichel A., Steffen A., Zimerman B., Schally A.V., Block N.L., Colton C.K., Ludwig S., Kersting S., Bonifacio E., Solimena M., Gendler Z., Rotem A., Barkai U., Bornstein S.R. Transplantation of human islets without immunosuppression. Proc Natl Acad Sci U S A 2013 Nov 19, 110(47):19054-19058.